Eli Lilly shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-stage Crohn’s disease trial and struck a deal to develop new cancer-targeting medicines.
Source: MarketWatch
21. May 2024 17:56
Eli Lilly shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-stage Crohn’s disease trial and struck a deal to develop new cancer-targeting medicines.
Source: MarketWatch